Evidence map›Paper›PMID 11867536›Full record

ArticleThe EMBO journal2002

The roX genes encode redundant male-specific lethal transcripts required for targeting of the MSL complex.

Victoria H Meller, Barbara P Rattner

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 278 citations in OpenAlex.

  1. Article
  2. Article
  3. Direct roles of long non-coding RNAs in transcription activation.Nature structural & molecular biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Sex-specific transcriptome dynamics ofGenes & development · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. N-terminus ofeLife · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Theme and variation in the evolution of insect sex determination.Journal of experimental zoology. Part B, Molecular and developmental evolution · 2023
    Review

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Victoria H MellerDepartment of Biology, Tufts University, Medford, MA 02155, USA. vmeller@tufts.edu
Barbara P Rattner
Tufts University · US

Funding

MOLECULAR GENETICS OF DOSAGE COMPENSATION IN DROSOPHILAR01GM058427 · NIGMS · WAYNE STATE UNIVERSITY · PI MELLER, VICTORIA H · 1999 to 2003
$695k
NIGMS NIH HHS GM58427NIGMS NIH HHS R01 GM058427
6 · The paper itself

Abstract

The roX1 and roX2 genes of Drosophila produce male-specific non-coding RNAs that co-localize with the Male-Specific Lethal (MSL) protein complex. This complex mediates up-regulation of the male X chromosome by increasing histone H4 acetylation, thus contributing to the equalization of X-linked gene expression between the sexes. Both roX genes overlap two of approximately 35 chromatin entry sites, DNA sequences proposed to act in cis to direct the MSL complex to the X chromosome. Although dosage compensation is essential in males, an intact roX1 gene is not required by either sex. We have generated flies lacking roX2 and find that this gene is also non-essential. However, simultaneous removal of both roX RNAs causes a striking male-specific reduction in viability accompanied by relocation of the MSL proteins and acetylated histone H4 from the X chromosome to autosomal sites and heterochromatin. Males can be rescued by roX cDNAs from autosomal transgenes, demonstrating the genetic separation of the chromatin entry and RNA-encoding functions. Therefore, the roX1 and roX2 genes produce redundant, male-specific lethal transcripts required for targeting the MSL complex.

Indexed as

Chromosomal Proteins, Non-HistoneDNA HelicasesGenes, InsectGenes, LethalAcetyltransferasesAnimalsChromatinDNA-Binding ProteinsDosage Compensation, GeneticDrosophila melanogasterDrosophila ProteinsFemaleGene DeletionGenetic Complementation TestHistone AcetyltransferasesHistonesAcetyltransferasesChromatinChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA HelicasesDrosophila ProteinsHistone AcetyltransferasesHistonesMacromolecular Substancesmle protein, Drosophilamof protein, Drosophilamsl-1 protein, Drosophilamsl-2 protein, Drosophilamsl-3 protein, DrosophilaNuclear ProteinsPabp2 protein, DrosophilaRepressor ProteinsRNARNA-Binding ProteinsRNA HelicasesroX1 protein, DrosophilaROX1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID11867536
PMCPMC125901
OpenAlexW2076566576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.